Bavarian Nordic AS (WBO:BAVA) Cyclically Adjusted Revenue per Share: € (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WBO:BAVA Bavarian Nordic AS WBO:BAVA
75 GF Score
Price €27.84
GF Value €22.69
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Bavarian Nordic AS Cyclically Adjusted Revenue per Share?

Bavarian Nordic AS WBO:BAVA +0.36% 75 Cyclically Adjusted Revenue per Share is € as of Jun. 2026. GuruFocus rates WBO:BAVA with a GF Score™ of 75/100 and a GF Value™ of €22.69 (Modestly Overvalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Bavarian Nordic AS's adjusted revenue per share for the three months ended in Jun. 2026 was €3.577. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is for the trailing ten years ended in Jun. 2026.

During the past 12 months, Bavarian Nordic AS's average Cyclically Adjusted Revenue Growth Rate was 15.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 12.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 12.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Bavarian Nordic AS was 12.80% per year. The lowest was 2.00% per year. And the median was 9.10% per year.

As of today (2026-09-20), Bavarian Nordic AS's current stock price is €27.84. Bavarian Nordic AS's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was . Bavarian Nordic AS's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bavarian Nordic AS was 13.57. The lowest was 3.21. And the median was 5.54.


Bavarian Nordic AS  (WBO:BAVA) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bavarian Nordic AS was 13.57. The lowest was 3.21. And the median was 5.54.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Bavarian Nordic AS Cyclically Adjusted Revenue per Share Related Terms


Bavarian Nordic AS Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Bavarian Nordic AS's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bavarian Nordic AS Cyclically Adjusted Revenue per Share Chart

Bavarian Nordic AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Bavarian Nordic AS Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

WBO:BAVA vs VRTX, REGN, MRNA: Cyclically Adjusted Revenue per Share Comparison

For the Biotechnology subindustry, Bavarian Nordic AS's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bavarian Nordic AS Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bavarian Nordic AS's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bavarian Nordic AS's Cyclically Adjusted PS Ratio falls into.


WBO:BAVA
75GF Score
Bavarian Nordic AS WBO:BAVA
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bavarian Nordic AS Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bavarian Nordic AS's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=3.577/122.9500*122.9500
=3.577

Current CPI (Jun. 2026) = 122.9500.

Bavarian Nordic AS Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 1.554 100.200 1.907
201612 1.409 100.300 1.727
201703 0.670 101.200 0.814
201706 1.344 101.200 1.633
201709 2.446 101.800 2.954
201712 0.135 101.300 0.164
201803 0.037 101.700 0.045
201806 0.285 102.300 0.343
201809 0.729 102.400 0.875
201812 0.595 102.100 0.717
201903 0.417 102.900 0.498
201906 0.333 102.900 0.398
201909 0.480 102.900 0.574
201912 0.986 102.900 1.178
202003 1.198 103.300 1.426
202006 1.607 103.200 1.915
202009 1.259 103.500 1.496
202012 0.599 103.400 0.712
202103 1.209 104.300 1.425
202106 0.780 105.000 0.913
202109 0.954 105.800 1.109
202112 1.095 106.600 1.263
202203 0.611 109.900 0.684
202206 1.025 113.600 1.109
202209 1.911 116.400 2.019
202212 2.459 115.900 2.609
202303 2.160 117.300 2.264
202306 3.422 116.400 3.615
202309 2.357 117.400 2.468
202312 4.282 116.700 4.511
202403 1.428 118.400 1.483
202406 2.447 118.500 2.539
202409 2.344 118.900 2.424
202412 3.579 118.900 3.701
202503 2.326 120.200 2.379
202506 2.846 120.700 2.899
202509 3.003 121.600 3.036
202512 2.417 121.180 2.452
202603 1.837 121.670 1.856
202606 3.577 122.950 3.577

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of € mean?
Bavarian Nordic AS (WBO:BAVA) has a Cyclically Adjusted Revenue per Share of € as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Bavarian Nordic AS and its competitors.
Is Bavarian Nordic AS's Cyclically Adjusted Revenue per Share too high?
Bavarian Nordic AS's current Cyclically Adjusted Revenue per Share is €. Overall, Bavarian Nordic AS has a GF Score™ of 75/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bavarian Nordic AS's Cyclically Adjusted Revenue per Share compare to VRTX and REGN?
Bavarian Nordic AS's Cyclically Adjusted Revenue per Share of € can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Biotechnology company?
A good Cyclically Adjusted Revenue per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Bavarian Nordic AS and its competitors. Bavarian Nordic AS's current Cyclically Adjusted Revenue per Share is €. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bavarian Nordic AS stock overvalued right now?
Based on GuruFocus' analysis, Bavarian Nordic AS (WBO:BAVA) is currently considered Modestly Overvalued. The stock's GF Value™ is €22.69, compared to a current price of €27.84 — trading 22.7% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €. Bavarian Nordic AS's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Bavarian Nordic AS (WBO:BAVA), the current Cyclically Adjusted Revenue per Share is € as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bavarian Nordic AS (WBO:BAVA) Overvalued in 2026?

Based on GuruFocus' analysis, Bavarian Nordic AS stock appears to be overvalued. The current stock price of €27.84 is trading 22.7% above its estimated GF Value™ of €22.69. GuruFocus considers Bavarian Nordic AS to be Modestly Overvalued.

Key valuation signals for WBO:BAVA:

  • Cyclically Adjusted Revenue per Share:
  • GF Value™: €22.69 vs. price of €27.84 (22.7% above fair value)
  • GF Score™: 75/100 with 3 warning signs

No single metric tells the full story. See the WBO:BAVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bavarian Nordic AS Business Description

Address Philip Heymans Alle 3, Hellerup, DNK, 2900
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The group is a supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and has a portfolio of travel vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora, VIMKUNYA and Vivotif.
75GF Score

Get the complete analysis for WBO:BAVA

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€27.84
Price
€22.69
GF Value